ST26 Sequence Listing Standard: Easing the Access to Sequence Data

According to international filing guidelines, sequence listings must be included in every patent application that discloses nucleotide and/or amino acid sequences. With the implementation of the new ST26 sequence listing standard on July 1, 2022, it is anticipated that the data structure for automatic data exchange and verification between patent offices and biological sequence search databases will be improved. Although ST26 is a WIPO (World Intellectual Property Organization) initiative, it is up to individual patent offices to decide how open the new sequence listings on public portals should be. The present standard, ST25, did not permit automated validation and data transmission, hence a new listing standard was required.

This essay will discuss the differences between ST25 and ST26, the drawbacks of ST25, the modifications made to the new standard by WIPO, its advantages, and much more. However, let's first provide a precise definition of what sequence listing actually is.

What is Sequence Listing?

The description of patent applications includes the nucleotide and/or amino acid sequence in the sequence listing (s). It is a requirement for biotech patents, including those for inventions involving biomarkers, antibodies, oligonucleotides, etc. To prevent any delays in the patent approval process, the sequence listings included in patent applications must adhere to the established filing standards. ST25 is the sequence listing standard that is currently in use.

Now that we have a better understanding of what sequence listing is, let's learn about the regulations that must be adhered to while submitting a patent application in the biotech industry.

Patent Rules regarding Sequence Listings

The following are important guidelines for sequence listings in patent applications:

1. Sequence listings that reveal a sequence of nucleotides or amino acids must be submitted with each patent application in computer-readable text format.

2. The Searching Authority will notify the applicant to submit the sequences if the international application discloses one or more nucleotide or amino acid sequences that are not provided in computer-readable text format. Additionally, the applicant must pay the Fifth Schedule's late furnishing cost within a month. If the applicant ignores the notice, the Searching Authority will continue and reasonably search the international application without the sequence listing.

As previously announced, a new sequence listing standard will take effect on July 1, 2022. We will now concentrate on the requirement for ST26.

Need for a New Sequence Listing Standard

The limitations of the standard in current use are the reason for the need for a new sequence listing standard. The list of them is below.

1. The standards of the INSDC (International Nucleotide Sequence Database Collaboration) were not met by the ST25 format.

2. There were conflicting interpretations and applications of the legislation by IP offices around the world.

3. Sequence kinds that are widespread today were not covered by ST25 rules (e.g., nucleotide analogs, D-amino acids, and branched sequences).

4. The data wasn't structured.

5. Data sharing and automatic validation were difficult with the ST25 format.

Let's now examine the modifications made possible by the new standard.

Sequence Listing Changes Introduced through ST26

The adjustments made by WIPO through ST26 are listed below.

1. To combat data loss and promote the exchange of data readable by both people and machines,.xml file types will be necessary.

2. There will be more possibilities for sequence annotation.

3. The organisms' options and names will be modified.

4. Three-letter codes will be favoured over single-letter ones.

5. The feature location's format has been changed.

6. Sequences in mixed modes will no longer be accepted.

7. Only the most recent priority information need be included (instead of all).

8. Additional, simpler revisions to the language requests have also been made.

Let's emphasise the main distinction between the old and new sequence listing standards to better grasp them.

Benefits of ST26 Sequence Listing Standard

The ST26 standard has a number of advantages, which are detailed below.

1. Under the new standard, applicants may provide a single sequence listing in a patent application for regional, national, or international purposes.

2. ST26 will improve the precision and calibre of sequence presentations.

3. It will make sequence data searching easier.

4. It will make it possible for sequence data to be shared electronically and added to digital databases.

5. ST26 will make sure that IP offices agree.

6. It will speed up IP offices' processing and increase automation of data validation.

7. Because of the way XML sequence listings are structured, submission quality will increase.

Creating Sequence Listings That Are ST26 Compliant

The WIPO Sequence programme can be used to transform outdated ST25 TXT sequence listings into the more modern ST26 XML format. This obligation to distribute sequence listings in accordance with....

To get more information, read the entire article about Sequence Listing.

Comments

Post a Comment

Popular posts from this blog

Patent Drafting and Prior Art: Strategies for Navigating the Patent Landscape

 Patent Drafting and Prior Art: Strategies for Navigating the Patent Landscape Patent drafting is the process of creating a detailed document that describes an invention and its components, as well as the steps for making and using it. Prior art, on the other hand, refers to existing public knowledge and technologies that may affect the novelty or non-obviousness of an invention. In the complex and constantly evolving world of patent law, it is essential to understand both of these concepts and how to navigate the patent landscape effectively. In this article, we will discuss some strategies for patent drafting and dealing with prior art. Start with a clear and concise description of the invention The first step in patent drafting is to create a detailed description of the invention. This should include information about what the invention is, how it works, and what makes it unique or different from existing technologies. It is important to be clear and concise in this description,...
Read more

IPR and National Biodiversity Authority: Guidelines for Biodiversity-Related IPR in India

The Biological Diversity Act, 2002 has lately been the subject of many revision proposals from the Indian Union Ministry of Environment, Forest and Climate Change. These adjustments seek to ensure sustainable use of components, control the conservation of biological variety, and foster fair benefit-sharing resulting from the use of Indian biological resources and community knowledge associated with them. The bill has an effect on the nation's biodiversity and IPR as well. For instance, under the proposed legislation, the National Biodiversity Authority must first approve any application for intellectual property rights based on Indian biological resources, such as a patent filing (NBA). Therefore, it is crucial for businesses and inventors to comprehend the prerequisites for biodiversity-related patent applications. The Biological Diversity Act, 2002, the agencies created under it, the amendment bill 2021, and different IPR and biodiversity rules in India are covered in this page. ...
Read more

FTO Search: A Cog in the Wheel of Patent Strategy

  In today's rapidly evolving technological landscape, the complexities surrounding Intellectual Property (IP) rights have intensified. As a result, organizations are increasingly dedicating substantial resources to safeguard and enforce their IP assets. Protecting your patent rights is crucial, but equally important is ensuring that you do not infringe on others' rights, as such infringements can significantly hinder your organization's growth. Consequently, conducting a freedom-to-operate analysis has become a standard practice for businesses aiming to mitigate infringement risks and ensure smooth market entry. Understanding Freedom to Operate Analysis Freedom to Operate (FTO) analysis, sometimes referred to as clearance search or infringement analysis, is a critical tool used to determine whether a product or process infringes on any active patent claims. This analysis not only identifies potential infringement risks but also aids in navigating licensing requirements, g...
Read more